Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1183 entries
Sorted by: Best Match Show Resources per page
[Clinical nursing. 6. Outlines of clinical training in nursing of adults. 4].

[Kango gijutsu] : [Nursing technique]

Suzuki M, Tsuboi Y.
PMID: 4494012
Kango Gijutsu. 1974 Feb;20(2):147-55.

No abstract available.

Cite
Suzuki M, Tsuboi Y. [Clinical nursing. 6. Outlines of clinical training in nursing of adults. 4]. Kango Gijutsu. 1974;20(2):147-55
Suzuki, M., & Tsuboi, Y. (1974). [Clinical nursing. 6. Outlines of clinical training in nursing of adults. 4]. [Kango gijutsu] : [Nursing technique], 20(2), 147-55.
Suzuki, M, and Tsuboi, Y. "[Clinical nursing. 6. Outlines of clinical training in nursing of adults. 4]." [Kango gijutsu] : [Nursing technique] vol. 20,2 (1974): 147-55.
Suzuki M, Tsuboi Y. [Clinical nursing. 6. Outlines of clinical training in nursing of adults. 4]. Kango Gijutsu. 1974 Feb;20(2):147-55. Japanese. PMID: 4494012.
Copy Download .nbib Format: NLM
[Management of hypertension for the local population].

[Hokenfu zasshi] The Japanese journal for public health nurse

Nakamura E, Tsuboi T.
PMID: 4492897
Hokenfu Zasshi. 1973 Nov;29(11):878-83.

No abstract available.

Cite
Nakamura E, Tsuboi T. [Management of hypertension for the local population]. Hokenfu Zasshi. 1973;29(11):878-83
Nakamura, E., & Tsuboi, T. (1973). [Management of hypertension for the local population]. [Hokenfu zasshi] The Japanese journal for public health nurse, 29(11), 878-83.
Nakamura, E, and Tsuboi, T. "[Management of hypertension for the local population]." [Hokenfu zasshi] The Japanese journal for public health nurse vol. 29,11 (1973): 878-83.
Nakamura E, Tsuboi T. [Management of hypertension for the local population]. Hokenfu Zasshi. 1973 Nov;29(11):878-83. Japanese. PMID: 4492897.
Copy Download .nbib Format: NLM
Immunoglobulin G4-related sclerosing cholecystitis presenting as gallbladder cancer: a case report.

Surgical case reports

Takahashi K, Ito H, Katsube T, Tsuboi A, Hashimoto M, Ota E, Mita K, Asakawa H, Hayashi T, Fujino K, Okamoto S.
PMID: 26943444
Surg Case Rep. 2015 Dec;1(1):120. doi: 10.1186/s40792-015-0123-4. Epub 2015 Dec 03.

Immunoglobulin G4 (IgG4)-related sclerosing disease is a systemic inflammatory syndrome, and an understanding of its characteristics is currently evolving. IgG4-related cholecystitis is a manifestation of IgG4-related sclerosing disease in the gallbladder. This case report describes the clinical, radiographic, and...

Cite
Takahashi K, Ito H, Katsube T, et al. Immunoglobulin G4-related sclerosing cholecystitis presenting as gallbladder cancer: a case report. Surg Case Rep. 2015;1(1):120doi: 10.1186/s40792-015-0123-4.
Takahashi, K., Ito, H., Katsube, T., Tsuboi, A., Hashimoto, M., Ota, E., Mita, K., Asakawa, H., Hayashi, T., Fujino, K., & Okamoto, S. (2015). Immunoglobulin G4-related sclerosing cholecystitis presenting as gallbladder cancer: a case report. Surgical case reports, 1(1), 120. https://doi.org/10.1186/s40792-015-0123-4
Takahashi, Kodai, et al. "Immunoglobulin G4-related sclerosing cholecystitis presenting as gallbladder cancer: a case report." Surgical case reports vol. 1,1 (2015): 120. doi: https://doi.org/10.1186/s40792-015-0123-4
Takahashi K, Ito H, Katsube T, Tsuboi A, Hashimoto M, Ota E, Mita K, Asakawa H, Hayashi T, Fujino K, Okamoto S. Immunoglobulin G4-related sclerosing cholecystitis presenting as gallbladder cancer: a case report. Surg Case Rep. 2015 Dec;1(1):120. doi: 10.1186/s40792-015-0123-4. Epub 2015 Dec 03. PMID: 26943444; PMCID: PMC4668245.
Copy Download .nbib Format: NLM
Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients.

Case reports in oncology

Imafuku K, Yoshino K, Yamaguchi K, Tsuboi S, Ohara K, Hata H.
PMID: 28512412
Case Rep Oncol. 2017 Apr 04;10(1):290-295. doi: 10.1159/000461576. eCollection 2017.

Vemurafenib is an inhibitor of the BRAF mutation and has been approved by the Food and Drug Administration as a treatment option for patients with unresectable melanoma without brain metastasis. In the literature, vemurafenib has been reported to be...

Cite
Imafuku K, Yoshino K, Yamaguchi K, et al. Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients. Case Rep Oncol. 2017;10(1):290-295doi: 10.1159/000461576.
Imafuku, K., Yoshino, K., Yamaguchi, K., Tsuboi, S., Ohara, K., & Hata, H. (2017). Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients. Case reports in oncology, 10(1), 290-295. https://doi.org/10.1159/000461576
Imafuku, Keisuke, et al. "Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients." Case reports in oncology vol. 10,1 (2017): 290-295. doi: https://doi.org/10.1159/000461576
Imafuku K, Yoshino K, Yamaguchi K, Tsuboi S, Ohara K, Hata H. Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients. Case Rep Oncol. 2017 Apr 04;10(1):290-295. doi: 10.1159/000461576. eCollection 2017. PMID: 28512412; PMCID: PMC5422723.
Copy Download .nbib Format: NLM
Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events.

Case reports in oncology

Imafuku K, Yoshino K, Yamaguchi K, Tsuboi S, Ohara K, Hata H.
PMID: 28512413
Case Rep Oncol. 2017 Apr 04;10(1):296-300. doi: 10.1159/000463379. eCollection 2017.

Nivolumab is a recently approved medication for the treatment of unresectable malignant melanoma. Many immune-related adverse events (irAEs) associated with nivolumab have been reported, such as pneumonitis, hepatitis, dermatitis, and thyroiditis. Prednisolone can effectively treat irAEs. However, it is...

Cite
Imafuku K, Yoshino K, Yamaguchi K, et al. Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events. Case Rep Oncol. 2017;10(1):296-300doi: 10.1159/000463379.
Imafuku, K., Yoshino, K., Yamaguchi, K., Tsuboi, S., Ohara, K., & Hata, H. (2017). Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events. Case reports in oncology, 10(1), 296-300. https://doi.org/10.1159/000463379
Imafuku, Keisuke, et al. "Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events." Case reports in oncology vol. 10,1 (2017): 296-300. doi: https://doi.org/10.1159/000463379
Imafuku K, Yoshino K, Yamaguchi K, Tsuboi S, Ohara K, Hata H. Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events. Case Rep Oncol. 2017 Apr 04;10(1):296-300. doi: 10.1159/000463379. eCollection 2017. PMID: 28512413; PMCID: PMC5422733.
Copy Download .nbib Format: NLM
Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.

Journal of diabetes investigation

Nino A, Okuda I, Wilson TH, Yue L, Nakajima H, Tsuboi M, Carr MC, Seino Y.
PMID: 28921915
J Diabetes Investig. 2017 Sep 16; doi: 10.1111/jdi.12749. Epub 2017 Sep 16.

AIMS/INTRODUCTION: The present phase 3, randomized, double-blind 24-week study with extension to 1 year assessed the efficacy and safety of albiglutide compared with placebo in Japanese patients with type 2 diabetes mellitus inadequately controlled by diet and exercise with...

Cite
Nino A, Okuda I, Wilson TH, et al. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. J Diabetes Investig. 2017;doi: 10.1111/jdi.12749.
Nino, A., Okuda, I., Wilson, T. H., Yue, L., Nakajima, H., Tsuboi, M., Carr, M. C., & Seino, Y. (2017). Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Journal of diabetes investigation, . https://doi.org/10.1111/jdi.12749
Nino, Antonio, et al. "Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study." Journal of diabetes investigation vol. (2017). doi: https://doi.org/10.1111/jdi.12749
Nino A, Okuda I, Wilson TH, Yue L, Nakajima H, Tsuboi M, Carr MC, Seino Y. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. J Diabetes Investig. 2017 Sep 16; doi: 10.1111/jdi.12749. Epub 2017 Sep 16. PMID: 28921915; PMCID: PMC5934244.
Copy Download .nbib Format: NLM
Safety and Efficacy of Two Trabecular Micro-Bypass Stents as the Sole Procedure in Japanese Patients with Medically Uncontrolled Primary Open-Angle Glaucoma: A Pilot Case Series.

Journal of ophthalmology

Shiba D, Hosoda S, Yaguchi S, Ozeki N, Yuki K, Tsubota K.
PMID: 28265466
J Ophthalmol. 2017;2017:9605461. doi: 10.1155/2017/9605461. Epub 2017 Feb 07.

No abstract available.

Cite
Shiba D, Hosoda S, Yaguchi S, et al. Safety and Efficacy of Two Trabecular Micro-Bypass Stents as the Sole Procedure in Japanese Patients with Medically Uncontrolled Primary Open-Angle Glaucoma: A Pilot Case Series. J Ophthalmol. 2017;2017:9605461doi: 10.1155/2017/9605461.
Shiba, D., Hosoda, S., Yaguchi, S., Ozeki, N., Yuki, K., & Tsubota, K. (2017). Safety and Efficacy of Two Trabecular Micro-Bypass Stents as the Sole Procedure in Japanese Patients with Medically Uncontrolled Primary Open-Angle Glaucoma: A Pilot Case Series. Journal of ophthalmology, 20179605461. https://doi.org/10.1155/2017/9605461
Shiba, Daisuke, et al. "Safety and Efficacy of Two Trabecular Micro-Bypass Stents as the Sole Procedure in Japanese Patients with Medically Uncontrolled Primary Open-Angle Glaucoma: A Pilot Case Series." Journal of ophthalmology vol. 2017 (2017): 9605461. doi: https://doi.org/10.1155/2017/9605461
Shiba D, Hosoda S, Yaguchi S, Ozeki N, Yuki K, Tsubota K. Safety and Efficacy of Two Trabecular Micro-Bypass Stents as the Sole Procedure in Japanese Patients with Medically Uncontrolled Primary Open-Angle Glaucoma: A Pilot Case Series. J Ophthalmol. 2017;2017:9605461. doi: 10.1155/2017/9605461. Epub 2017 Feb 07. PMID: 28265466; PMCID: PMC5318622.
Copy Download .nbib Format: NLM
Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species.

ZooKeys

Tsujii K, Mita T, Terayama M, Pham HT, Okajima S.
PMID: 26155069
Zookeys. 2015 Jun 08;(507):25-30. doi: 10.3897/zookeys.507.9773. eCollection 2015.

Formosiepyrisvietnamensis sp. n. (Hymenoptera: Bethylidae) is described based on material collected from Da Lat, southern Vietnam. This is the first record of Formosiepyris Terayama from Vietnam. The new species can be distinguished from other Formosiepyris species by a narrow...

Cite
Tsujii K, Mita T, Terayama M, et al. Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species. Zookeys. 2015;(507):25-30doi: 10.3897/zookeys.507.9773.
Tsujii, K., Mita, T., Terayama, M., Pham, H. T., & Okajima, S. (2015). Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species. ZooKeys, (507), 25-30. https://doi.org/10.3897/zookeys.507.9773
Tsujii, Kentaro, et al. "Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species." ZooKeys vol. ,507 (2015): 25-30. doi: https://doi.org/10.3897/zookeys.507.9773
Tsujii K, Mita T, Terayama M, Pham HT, Okajima S. Discovery of the genus Formosiepyris Terayama, (Hymenoptera, Bethylidae) in Vietnam, with a description of a new species. Zookeys. 2015 Jun 08;(507):25-30. doi: 10.3897/zookeys.507.9773. eCollection 2015. PMID: 26155069; PMCID: PMC4490217.
Copy Download .nbib Format: NLM
Bioengineered Lacrimal Gland Organ Regeneration in Vivo.

Journal of functional biomaterials

Hirayama M, Tsubota K, Tsuji T.
PMID: 26264034
J Funct Biomater. 2015 Jul 30;6(3):634-49. doi: 10.3390/jfb6030634.

The lacrimal gland plays an important role in maintaining a homeostatic environment for healthy ocular surfaces via tear secretion. Dry eye disease, which is caused by lacrimal gland dysfunction, is one of the most prevalent eye disorders and causes...

Cite
Hirayama M, Tsubota K, Tsuji T. Bioengineered Lacrimal Gland Organ Regeneration in Vivo. J Funct Biomater. 2015;6(3):634-49doi: 10.3390/jfb6030634.
Hirayama, M., Tsubota, K., & Tsuji, T. (2015). Bioengineered Lacrimal Gland Organ Regeneration in Vivo. Journal of functional biomaterials, 6(3), 634-49. https://doi.org/10.3390/jfb6030634
Hirayama, Masatoshi, et al. "Bioengineered Lacrimal Gland Organ Regeneration in Vivo." Journal of functional biomaterials vol. 6,3 (2015): 634-49. doi: https://doi.org/10.3390/jfb6030634
Hirayama M, Tsubota K, Tsuji T. Bioengineered Lacrimal Gland Organ Regeneration in Vivo. J Funct Biomater. 2015 Jul 30;6(3):634-49. doi: 10.3390/jfb6030634. PMID: 26264034; PMCID: PMC4598675.
Copy Download .nbib Format: NLM
Giving social support to outside family may be a desirable buffer against depressive symptoms in community-dwelling older adults: Japan gerontological evaluation study.

BioPsychoSocial medicine

Tsuboi H, Hirai H, Kondo K.
PMID: 27226808
Biopsychosoc Med. 2016 May 24;10:18. doi: 10.1186/s13030-016-0064-6. eCollection 2016.

BACKGROUND: Depression is the leading cause of impaired quality of life and burden upon societies. Social supports can buffer against depressive symptoms effectively. The aim of this study is to determine the type of social support to have a...

Cite
Tsuboi H, Hirai H, Kondo K. Giving social support to outside family may be a desirable buffer against depressive symptoms in community-dwelling older adults: Japan gerontological evaluation study. Biopsychosoc Med. 2016;10:18doi: 10.1186/s13030-016-0064-6.
Tsuboi, H., Hirai, H., & Kondo, K. (2016). Giving social support to outside family may be a desirable buffer against depressive symptoms in community-dwelling older adults: Japan gerontological evaluation study. BioPsychoSocial medicine, 1018. https://doi.org/10.1186/s13030-016-0064-6
Tsuboi, Hirohito, et al. "Giving social support to outside family may be a desirable buffer against depressive symptoms in community-dwelling older adults: Japan gerontological evaluation study." BioPsychoSocial medicine vol. 10 (2016): 18. doi: https://doi.org/10.1186/s13030-016-0064-6
Tsuboi H, Hirai H, Kondo K. Giving social support to outside family may be a desirable buffer against depressive symptoms in community-dwelling older adults: Japan gerontological evaluation study. Biopsychosoc Med. 2016 May 24;10:18. doi: 10.1186/s13030-016-0064-6. eCollection 2016. PMID: 27226808; PMCID: PMC4879739.
Copy Download .nbib Format: NLM
Fatigue-related differences in erector spinae between prepubertal children and young adults using surface electromyographic power spectral analysis.

Journal of back and musculoskeletal rehabilitation

Tanina H, Nishimura Y, Tsuboi H, Sakata T, Nakamura T, Murata KY, Arakawa H, Umezu Y, Tajima F.
PMID: 27232083
J Back Musculoskelet Rehabil. 2016 May 20; doi: 10.3233/BMR-160705. Epub 2016 May 20.

BACKGROUND: The erector spinae is more resistant to fatigue in adult women than men. However, no study has reported the sex differences in back muscle fatigue in children.OBJECTIVE: The aim of this study was to evaluate the fatigability of...

Cite
Tanina H, Nishimura Y, Tsuboi H, et al. Fatigue-related differences in erector spinae between prepubertal children and young adults using surface electromyographic power spectral analysis. J Back Musculoskelet Rehabil. 2016;doi: 10.3233/BMR-160705.
Tanina, H., Nishimura, Y., Tsuboi, H., Sakata, T., Nakamura, T., Murata, K. Y., Arakawa, H., Umezu, Y., & Tajima, F. (2016). Fatigue-related differences in erector spinae between prepubertal children and young adults using surface electromyographic power spectral analysis. Journal of back and musculoskeletal rehabilitation, . https://doi.org/10.3233/BMR-160705
Tanina, Hideaki, et al. "Fatigue-related differences in erector spinae between prepubertal children and young adults using surface electromyographic power spectral analysis." Journal of back and musculoskeletal rehabilitation vol. (2016). doi: https://doi.org/10.3233/BMR-160705
Tanina H, Nishimura Y, Tsuboi H, Sakata T, Nakamura T, Murata KY, Arakawa H, Umezu Y, Tajima F. Fatigue-related differences in erector spinae between prepubertal children and young adults using surface electromyographic power spectral analysis. J Back Musculoskelet Rehabil. 2016 May 20; doi: 10.3233/BMR-160705. Epub 2016 May 20. PMID: 27232083.
Copy Download .nbib Format: NLM
A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis.

Neuro-oncology practice

Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI.
PMID: 27833757
Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07.

BACKGROUND: Brain radiation necrosis (BRN) can be a complication of radiotherapy for primary and secondary brain tumors, as well as head and neck tumors. Since vascular endothelial growth factor (VEGF) is also a vascular permeability factor in the brain,...

Cite
Furuse M, Nonoguchi N, Kuroiwa T, et al. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016;3(4):272-280doi: 10.1093/nop/npv064.
Furuse, M., Nonoguchi, N., Kuroiwa, T., Miyamoto, S., Arakawa, Y., Shinoda, J., Miwa, K., Iuchi, T., Tsuboi, K., Houkin, K., Terasaka, S., Tabei, Y., Nakamura, H., Nagane, M., Sugiyama, K., Terasaki, M., Abe, T., Narita, Y., Saito, N., Mukasa, A., Ogasawara, K., Beppu, T., Kumabe, T., Nariai, T., Tsuyuguchi, N., Nakatani, E., Kurisu, S., Nakagawa, Y., & Miyatake, S. I. (2016). A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neuro-oncology practice, 3(4), 272-280. https://doi.org/10.1093/nop/npv064
Furuse, Motomasa, et al. "A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis." Neuro-oncology practice vol. 3,4 (2016): 272-280. doi: https://doi.org/10.1093/nop/npv064
Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07. PMID: 27833757; PMCID: PMC5099992.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1183 entries